Related Experiment Video
Updated: Feb 8, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
Posaconazole in immunocompromised pediatric patients
Edoardo Bruno Vicenzi1, Simone Cesaro1
1a Pediatric Hematology Oncology , Azienda Ospedaliera Universitaria Integrata , Verona , Italy.
Posaconazole is safe and effective for treating fungal infections in children. Dosing and drug monitoring are key to optimizing its effectiveness in pediatric patients.
Area of Science:
- Mycology
- Pediatric Pharmacology
- Infectious Diseases
Background:
- Posaconazole, a broad-spectrum triazole antifungal, is widely used in adults.
- Its off-label use in pediatric patients is common, but pediatric pharmacokinetics, safety, and efficacy require further investigation.
Purpose of the Study:
- To review pediatric studies on posaconazole use from 2010-2017.
- To analyze the correlation between oral dose, plasma levels, safety, and effectiveness in children.
- To provide expert commentary on optimizing posaconazole therapy in pediatric populations.
Main Methods:
- Systematic review of pediatric studies published between 2010 and 2017.
- Analysis of prophylactic and therapeutic use of posaconazole.
- Evaluation of factors affecting absorption, safety, and efficacy.
Main Results:
- Posaconazole is well-tolerated in children with a low incidence of adverse effects.
- Absorption is influenced by gastric pH, mucositis, and drug interactions.
- No direct correlation exists between daily dose and trough plasma concentration due to saturable absorption.
Conclusions:
- Posaconazole is safe and effective for fungal infections in immunocompromised children.
- Body-weight-based dosing and therapeutic drug monitoring are recommended.
- Further research on new posaconazole formulations in children is needed.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Patient-centered Care
Drug Dosing: Geriatric Patients

